Published 20 February 2015 DPP-4 inhibitors are a group of drugs used to treat type 1 diabetes that lower high blood usgar levels by stimulating insulin production in the body. Researchers at Lund University in Sweden have now discovered that DPP-4 inhibitors are also effective against low blood sugar levels. The study, which was carried out on mice, has been published in the journal Diabetologia.

https://www.ludc.lu.se/article/diabetes-drug-could-protect-against-low-blood-sugar - 2025-03-17

Published 25 March 2011 Charlotte Ling, researcher at Lund University Diabetes Centre, receives this year´s Novo Nordisk Foundation Excellence Project grant, five millions Danish crowns allocated during five years. Her project is about exploring whether epigenetic factors are underlying the development of Type 2 Diabetes. - This means very much to me and my research group. We will be able to expan

https://www.ludc.lu.se/article/large-grant-exporing-epigenetics-diabetes - 2025-03-17

Published 13 April 2011 No one can explain this strange phenomenon. The majority of type 2 diabetics who undergo metabolic surgery recover from diabetes only a few days after the procedure, long before any weight loss has occurred. Now researchers at Lund University Diabetes Centre plan to find out what is happening by studying both patients and pigs before and after metabolic surgery. - Since the

https://www.ludc.lu.se/article/how-can-metabolic-surgery-cure-diabetes-so-fast - 2025-03-17

Published 13 June 2011 Sofia Enhörning is the younger researcher in Scandinavia who wrote the best scientific article of the year within diabetes research. This means the Scandinavian Society for the Study of Diabetes (SSSD) which gives away the prize to her at the recent congress in Reykjavik.  - Really positive. And an acknowledgement that we have discovered something that others also find impor

https://www.ludc.lu.se/article/prize-best-scientific-article-scandinavia - 2025-03-17

Published 21 June 2011 Despite the disappointing results in trying to treat children suffering from type 1 diabetes with the GAD vaccine, the treatment has not been written off entirely. DIAPREV-IT, the study in which healthy high-risk children are vaccinated, is continuing as planned, and now with more money behind it. "I am still hopeful that the GAC vaccine will work", says Helena Elding Larsso

https://www.ludc.lu.se/article/still-hope-gad-diabetes-vaccine - 2025-03-17

Published 22 June 2011 Professor Olle Melander at Lund University Diabetes Centre and Skåne University Hospital in Malmö recieves Heart- and Lung Foundation´s large grant of 15 millions swedish crowns. By investigating the genome in tens of thousands has Olle Melander succeeded to identify markers in the blood which increase the risk of suffering from cardiovascular diseases. The next step is to i

https://www.ludc.lu.se/article/heart-research-recieves-15-millions-swedish-crowns - 2025-03-17

Published 14 November 2011 The fact that diabetes rases the risk of certain types of cancer is already well known, but the reasons have been unclear. Now researchers at Lund University in Sweden have mapped a molecular link that explains the connection between the two widespread diseases. Developing type 2 diabetes is a lengthy process. An early sign that it has begun is high levels of insulin in

https://www.ludc.lu.se/article/molecular-link-between-diabetes-and-cancer-described - 2025-03-17

Published 5 December 2011 Despite of more advanced methods than in the routin care it will not be determined which kind of diabetes every fifth new diabetic patient is suffering from. In the ANDIS-project (All New Diabetics In Scania) the concepts will be sorted out. ANDIS also shows that one form of diabetes, LADA, which 15 years ago not even was described is twice as common today as type 1 diabe

https://www.ludc.lu.se/article/uncertain-diagnosis-every-fifth-diabetes-patient - 2025-03-17

Published 29 February 2012 DPCon2012 Conference Co-chairmen George Andros, MD, and David G. Armstrong, DPM, MD, PhD, are pleased to announce that the Edward James Olmos Award for Advocacy in Amputation Prevention Honoree for 2012 is Jan Apelqvist, MD, PhD. One of the world´s most distinguished experts on the diabetic foot, diabetes-related complications and wound management, a noted researcher, a

https://www.ludc.lu.se/article/2012-edward-james-olmos-award-advocacy-amputation-prevention - 2025-03-17

Published 8 March 2012 For the eight year in a row, Diabetes Research Day is arranged by the Diabetes Programme at Lund University. Apart from several scientific lectures, two awards are handed out. The award that is presented to a PhD student at Lund University Diabetes Centre (LUDC) this year goes to Cecilia Nagorny. She receives this year´s student award in competition with a lot of other PhD s

https://www.ludc.lu.se/article/awarded-mapping-hormone-darkness - 2025-03-17

Published 15 June 2012 International experts has on behalf of the Swedish Research Council evaluated the first five years activity of Lund University Diabetes Centre (LUDC). The half time evaluation is underlying for the continous grant for the coming five years. All together the rating is "Very well accomplished". 2006 the Research Council and the Research Council for Environment, Agricultural Sc

https://www.ludc.lu.se/article/scientific-grade-world-class-commendation-and-resumed-confidence - 2025-03-17

Published 16 August 2012 The Anders Jahre Senior Medical Prize for 2012 of one million Norwegian crowns is awarded to professor Leif Groop, coordinator of Lund University Diabetes Centre. He receives the prize for his ground-breaking research on diabetes, especially for his identification of hereditary factors that predispose to this disease group. Via extensive population-based studies Professor

https://www.ludc.lu.se/article/2012-jahre-prize-awarded-professor-leif-groop - 2025-03-17

Published 28 August 2012 Using a new method, diabetes researchers at Lund University, Sweden, have been able to reveal more of the genetic complexity behind type 2 diabetes. The new research findings have been achieved as a result of access to human insulin-producing cells from deceased donors and through not only studying one gene variant, but many genes and how thay influcence the level of the g

https://www.ludc.lu.se/article/broader-approach-provides-new-insight-diabetes-genes - 2025-03-17

Published 24 September 2012 Could a capsule of insulin crystals a day stop the development of type 1 diabetes? There are indications that this could be the case. In the international TrialNet study, which follows relatives of individuals with type 1 diabetes, researchers are investigating whether oral insulin could prevent or delay the disease. Something to offerType 1 diabetes is the autoimmune f

https://www.ludc.lu.se/article/could-oral-insulin-prevent-or-delay-diabetes - 2025-03-17

Published 7 November 2012 When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be pTextut in place. Researchers at Lund University have now

https://www.ludc.lu.se/article/protein-reveals-diabetes-risk-many-years-advance - 2025-03-17

Published 20 December 2012 Researchers at Lund University, Sweden, are studying whether it is possible to prevent obesity, diabetes and cardiovascular disease by reducing levels of the hormone vasopressin in the blood. 
- If you dilute the blood by drinking water, the body releases less of the hormone vasopressin, which can potentially lead to diabetes, says Sofia Enhörning, a doctor who has recen

https://www.ludc.lu.se/article/could-normal-water-prevent-diabetes-obesity-and-cardiovascular-disease - 2025-03-17

Published 31 January 2013 Anders Rosengren and Ola Hansson from Lund University Diabetes Centre has been granted with 50.000 euro each from the Bo & Kerstin Hjelt Foundation for type 2 diabetes research. The 2013 grant will finance Anders Rosengrens project entitled "New anti-diabetic treatments through gene network analysis" and the project led by Ola Hansson is entitled "Mechanisms whereby genet

https://www.ludc.lu.se/article/new-grants-hjelt-foundation - 2025-03-17

Published 12 March 2013 Type 2 diabetes has strong hereditary tendencies and the genes we are born with cannot be changed. However, new research from Lund University in Sweden shows that we can modify the function of the genes through the epigenetic changes that take place in the course of life. Epigenetic changes are usually described as a link between heredity and environment and come about as a

https://www.ludc.lu.se/article/new-clues-hunt-heredity-type-2-diabetes - 2025-03-17

Published 30 April 2013 The majority of patients with type 2 diabetes who undergo a gastric bypass operation recover from the disease within a few days of the operation, long before their body weight falls. No one knows how this happens, but researchers at Lund University Diabetes Centre in Sweden have now come up with a partial answer. In the long term, we aim to identify new treatment strategies

https://www.ludc.lu.se/article/early-partial-answer-why-obesity-operations-cause-remission-diabetes - 2025-03-17

Published 22 May 2013 In recent years, researchers have discovered around 70 genetic risk variants for diabetes, but still TCF7L2, known as the diabetes gene, is the gene that carries with it the largest risk of developing type 2 diabetes. Using a new method called exon skipping, Ola Hansson at Lund University Diabetes Centre (LUDC) wants to learn more about TCF7L2 by studying new ways of delaying

https://www.ludc.lu.se/article/method-which-repairs-damaged-genes - 2025-03-17